News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Covidien (COV) Expands Global Research and Development Presence



3/8/2012 6:44:48 AM

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien (NYSE:COV), a leading global provider of healthcare products, today announced the opening of four research and development (R&D) centers. The R&D facilities are located in: Boulder, Colorado; Hyderabad, India; Irvine, California; and Trevoux, France.

Read at BioSpace.com


comments powered by Disqus
Covidien
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES